Literature DB >> 33968392

Hepatobiliary Manifestations of Short Bowel Syndrome and Intestinal Failure-Associated Liver Disease.

Jennifer Wang1, Dejan Micic1.   

Abstract

Entities:  

Year:  2021        PMID： 33968392      PMCID： PMC8087921          DOI： 10.1002/cld.1053

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  16 in total

1.  Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation.

Authors:  Bita V Naini; Charles R Lassman
Journal:  Hum Pathol       Date:  2011-11-09       Impact factor: 3.466

2.  Comparison of intestinal lengthening procedures for patients with short bowel syndrome.

Authors:  Debra Sudan; Jon Thompson; Jean Botha; Wendy Grant; Dean Antonson; Steve Raynor; Alan Langnas
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

3.  Ultra-short bowel is an independent risk factor for liver fibrosis in adults with home parenteral nutrition.

Authors:  Dominique Cazals-Hatem; Lore Billiauws; Pierre-Emmanuel Rautou; Vanessa Bondjemah; Nicolas Poté; Olivier Corcos; Valérie Paradis; Francisca Joly
Journal:  Liver Int       Date:  2017-09-02       Impact factor: 5.828

4.  ESPEN guidelines on chronic intestinal failure in adults.

Authors:  Loris Pironi; Jann Arends; Federico Bozzetti; Cristina Cuerda; Lyn Gillanders; Palle Bekker Jeppesen; Francisca Joly; Darlene Kelly; Simon Lal; Michael Staun; Kinga Szczepanek; André Van Gossum; Geert Wanten; Stéphane Michel Schneider
Journal:  Clin Nutr       Date:  2016-02-08       Impact factor: 7.324

5.  Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Sophie A Fillon; J Kirk Harris; Mark A Lovell; Milton J Finegold; Ronald J Sokol
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

6.  Effects of two different lipid emulsions on antioxidant status, lipid peroxidation and parenteral nutrition- related cholestasis in premature babies, a randomized-controlled study.

Authors:  Hacer Yapicioglu Yildizdas; Burak Poyraz; Guluzar Atli; Yasar Sertdemir; Kurthan Mert; Ferda Ozlu; Mehmet Satar
Journal:  Pediatr Neonatol       Date:  2018-08-02       Impact factor: 2.083

7.  Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease.

Authors:  M Isabel Fiel; Bernhard Sauter; Hai-Shan Wu; Gonzalo Rodriguez-Laiz; Gabriel Gondolesi; Kishore Iyer; Thomas D Schiano
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08       Impact factor: 11.382

8.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

9.  Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria.

Authors:  Anna Simona Sasdelli; Federica Agostini; Caterina Pazzeschi; Mariacristina Guidetti; Simon Lal; Loris Pironi
Journal:  Clin Nutr       Date:  2018-05-08       Impact factor: 7.324

10.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.